Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34807248.
- Also identified by DOI 10.1001/jama.2021.21699 and PMC identifier 8609457.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This population-based study evaluates the short-term risk of severe cardiovascular events among French residents aged 75 years or older after receipt of the BNT162b2 mRNA COVID-19 vaccination.
Medical subject headings
- BNT162 Vaccine
- Myocardial Infarction
- Pulmonary Embolism
- Stroke